BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2024 11:53:48 AM | Browse: 49 | Download: 248
 |
Received |
|
2024-07-24 11:31 |
|
Peer-Review Started |
|
2024-07-24 11:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-09 10:53 |
|
Revised |
|
2024-08-20 06:52 |
|
Second Decision |
|
2024-08-21 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-21 05:19 |
|
Articles in Press |
|
2024-08-21 05:19 |
|
Publication Fee Transferred |
|
2024-08-26 03:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-02 06:26 |
|
Publish the Manuscript Online |
|
2024-09-18 11:53 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Diagnostic value of serum vascular endothelial growth factor and interleukin-17 in primary hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qi Tian, Hui Zeng, Qi-Quan Lu, Hai-Ying Xie and Yong Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yong Li, MMed, Doctor, Doctor, Department of Oncology Hematology, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, No. 53 Mohu Road, Hanyang District, Wuhan 430050, Hubei Province, China. yongliandy@163.com |
| Key Words |
Primary liver cancer; Vascular endothelial growth factor; Interleukin-17; Serum level; Diagnostic value; Correlation |
| Core Tip |
The incidence and mortality rates of primary hepatocellular carcinoma (PHC) have been increasing. Despite significant advancements in medical care, improving treatment outcomes and prognosis for liver cancer remains a global challenge. This study measured the levels of vascular endothelial growth factor (VEGF) and interleukin (IL)-17 in the serum of PHC patients using Enzyme-Linked Immunosorbent Assay, with healthy individuals as controls. This study aimed to assess changes in serum VEGF and IL-17 levels and evaluate their diagnostic efficacy for PHC while exploring their correlations with patients’ clinicopathological characteristics. Our findings confirm that VEGF and IL-17 can serve as valuable reference indicators for the early diagnosis and treatment guidance of PHC, offering crucial insights for enhancing early management strategies. |
| Publish Date |
2024-09-18 11:53 |
| Citation |
<p>Tian Q, Zeng H, Lu QQ, Xie HY, Li Y. Diagnostic value of serum vascular endothelial growth factor and interleukin-17 in primary hepatocellular carcinoma. <i>World J Gastrointest Surg</i> 2024; 16(9): 2934-2941</p> |
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i9/2934.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i9.2934 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
